SEC Comment Letter for New You, Inc. (CIK 0001372184) — Jul 16, 2021
New You, Inc. (CIK 0001372184)
Date: July 16, 2021 · CIK: 0001372184 · Accession: 0000000000-21-008812
AI Filing Summary & Sentiment
File numbers found in text: 000-52668
Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
United States securities and exchange commission logo
July 16, 2021
John Driscoll
Chief Financial Officer
New You, Inc.
6351 Yarrow Drive
Suite E
Carlsbad, CA 92011
Re: New You, Inc.
Form 10-K for the
Fiscal Year Ended December 31, 2020
Filed April 8, 2021
Amendment No.1 to
Form 10-Q for the Fiscal Quarter Ended March 31, 2021
Filed May 25, 2021
File No. 000-52668
Dear Mr. Driscoll:
We have limited our review of your filing to the financial
statements and related
disclosures and have the following comments. In some of our comments, we
may ask you to
provide us with information so we may better understand your disclosure.
Please respond to these comments within ten business days by
providing the requested
information or advise us as soon as possible when you will respond. If
you do not believe our
comments apply to your facts and circumstances, please tell us why in
your response.
After reviewing your
response to these comments, we may have additional comments.
Form 10-K for the Fiscal Year Ended December 31, 2020
Item 9A. Controls and Procedures
Material Weakness in Internal Control over Financial Reporting, page 17
1. Please amend the filing
to provide all of the disclosures required by Item 308(a) of
Regulation S-K
regarding management s assessment of internal control over financial
reporting and address
the following:
Include a
statement that management is responsible for establishing and maintaining
adequate internal
control over financial reporting. Refer to Item 308(a)(1).
Identify the
framework used by management to evaluate internal control over
financial
reporting, whether the criteria set forth by COSO or another framework.
John Driscoll
New You, Inc.
July 16, 2021
Page 2
Refer to Item 308(a)(2).
Include a definitive statement on whether your internal control
over financial
reporting is effective or not effective at the end of your fiscal
year. Please be advised
that because you have material weaknesses, you are not permitted
to conclude that
your internal control over financial reporting is effective.
Refer to Item 308(a)(3).
Amendment No.1 to Form 10-Q for the Fiscal Quarter Ended March 31, 2021
Note 12. Subsequent Events, page 16
2. We note that on May 3, 2021 you entered into an Exchange Agreement
with ST Brands,
Inc. to acquire all of its issued and outstanding common stock. Please
tell us how you
accounted for and valued this transaction and clarify whether you will
file the historical
financial statements of the business acquired, along with a pro forma
presentation
illustrating the effects of the transaction, to comply with Rule 8-04
and Rule 8-05 of
Regulation S-X, and Item 9.01 of Form 8-K. Please submit the analyses
and the tests of
significance that you performed in your application of this guidance.
In closing, we remind you that the company and its management are
responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review,
comments, action or
absence of action by the staff.
You may contact David Burton at (202) 551-3626 or Kevin Kuhar,
Accounting Branch
Chief, at (202) 551-3662 with any questions.
FirstName LastNameJohn Driscoll Sincerely,
Comapany NameNew You, Inc.
Division of
Corporation Finance
July 16, 2021 Page 2 Office of Life
Sciences
FirstName LastName
</TEXT>
</DOCUMENT>